Company Overview
TissueGen is a medical device company whose patented technology enables creation of biodegradable polymer devices with unique drug delivery capabilities. Because its proprietary manufacturing process occurs at room temperature, the company can incorporate biologically active agents (e.g. therapeutic proteins) into its devices. TissueGen is focusing initial product development efforts on vascular stents - an application with a large dynamic market and for which our technology is ideally suited. By using biodegradable polymers with second-generation drugs such as growth factors or enzymes, TissueGen is designing vascular stents that offer breakthrough treatment capability.

For future opportunities, the company's technology is suitable to many additional markets and applications, providing a diversified pipeline of products or licensing opportunities for continued growth.

Research and Business Development
TissueGen works with selected business partners to develop its proprietary technology. The company can license its technology to partners in specific fields of use to enable powerful drug delivery capability to be incorporated into partners' specialized medical devices and create powerful, next-generation capability.

For information on TissueGen and its technology, or to inquire about business development opportunities, contact the company at:

TissueGen, Inc.
2110 Research Row, Ste. 527
Dallas, TX 75235
Attn: Keith Brown

Phone: (214) 351-1922
Email: kbrown@tissuegen.com